<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/T/Toremifene.xml">
<title>Toremifene RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/T/Toremifene.xml</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-11-06T20:41+25:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Toremifene RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/BioPharmaToday/statuses/5376357672" />
  <rdf:li rdf:resource="http://twitter.com/pharmalive/statuses/5370628212" />
  <rdf:li rdf:resource="http://twitter.com/AliciaSpeaks/statuses/5370272222" />
  <rdf:li rdf:resource="http://twitter.com/prostatecancers/statuses/5369346800" />
  <rdf:li rdf:resource="http://twitter.com/eyeonfda/statuses/5367169518" />
  <rdf:li rdf:resource="http://twitter.com/biotechrss/statuses/5366229450" />
  <rdf:li rdf:resource="http://twitter.com/BiotechWorld/statuses/5365947475" />
  <rdf:li rdf:resource="http://twitter.com/FierceBiotech/statuses/5365831905" />
  <rdf:li rdf:resource="http://twitter.com/BiotechNews/statuses/5365800432" />
  <rdf:li rdf:resource="http://twitter.com/techflypaper/statuses/5365122309" />
  <rdf:li rdf:resource="http://twitter.com/cafepharma/statuses/5364993892" />
  <rdf:li rdf:resource="http://twitter.com/biotechnology/statuses/5363874752" />
  <rdf:li rdf:resource="http://twitter.com/pharmaceutical/statuses/5363872002" />
  <rdf:li rdf:resource="http://twitter.com/PharmaNews/statuses/5363606737" />
  <rdf:li rdf:resource="http://twitter.com/biotechrss/statuses/5363606714" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/BioPharmaToday/statuses/5376357672">
<title>FDA&#x27;s &#x22;Complete Response&#x22; On GTx&#x27;s Toremifene Moves The Goal Posts, CEO Says http://bit.ly/3BEyCF</title>
<link>http://twitter.com/BioPharmaToday/statuses/5376357672</link>
<description><![CDATA[FDA&apos;s &quot;Complete Response&quot; On GTx&apos;s Toremifene Moves The Goal Posts, CEO Says http://bit.ly/3BEyCF]]></description>
</item>

<item rdf:about="http://twitter.com/pharmalive/statuses/5370628212">
<title>GTx Says FDA Asks for More Toremifene Data - http://tinyurl.com/yd5om5u</title>
<link>http://twitter.com/pharmalive/statuses/5370628212</link>
<description><![CDATA[GTx Says FDA Asks for More Toremifene Data - http://tinyurl.com/yd5om5u]]></description>
</item>

<item rdf:about="http://twitter.com/AliciaSpeaks/statuses/5370272222">
<title>GTx Shares Fall On Lack Of Approval For Bone Drug: GTx has a lower-dose version of toremifene citrate in a Phas.. http://bit.ly/15T3fP</title>
<link>http://twitter.com/AliciaSpeaks/statuses/5370272222</link>
<description><![CDATA[GTx Shares Fall On Lack Of Approval For Bone Drug: GTx has a lower-dose version of toremifene citrate in a Phas.. http://bit.ly/15T3fP]]></description>
</item>

<item rdf:about="http://twitter.com/prostatecancers/statuses/5369346800">
<title>Prostate Cancer: FDA issues a Complete Response Letter for GTx&#x27; toremifene NDA: GTx, Inc. today.. http://bit.ly/41AWz5</title>
<link>http://twitter.com/prostatecancers/statuses/5369346800</link>
<description><![CDATA[Prostate Cancer: FDA issues a Complete Response Letter for GTx&apos; toremifene NDA: GTx, Inc. today.. http://bit.ly/41AWz5]]></description>
</item>

<item rdf:about="http://twitter.com/eyeonfda/statuses/5367169518">
<title>GTx Receives Complete Response Letter from FDA for Toremifene 80 mg http://ow.ly/yEgp</title>
<link>http://twitter.com/eyeonfda/statuses/5367169518</link>
<description><![CDATA[GTx Receives Complete Response Letter from FDA for Toremifene 80 mg http://ow.ly/yEgp]]></description>
</item>

<item rdf:about="http://twitter.com/biotechrss/statuses/5366229450">
<title>FierceBiotech: GTx shares blitzed by FDA&#x27;s toremifene rejection: Shares of GTx (GTXI) tumbled 34 .. http://bit.ly/2LiIKL</title>
<link>http://twitter.com/biotechrss/statuses/5366229450</link>
<description><![CDATA[FierceBiotech: GTx shares blitzed by FDA&apos;s toremifene rejection: Shares of GTx (GTXI) tumbled 34 .. http://bit.ly/2LiIKL]]></description>
</item>

<item rdf:about="http://twitter.com/BiotechWorld/statuses/5365947475">
<title>GTx shares blitzed by FDA&#x27;s toremifene rejection http://bit.ly/2YcRd2</title>
<link>http://twitter.com/BiotechWorld/statuses/5365947475</link>
<description><![CDATA[GTx shares blitzed by FDA&apos;s toremifene rejection http://bit.ly/2YcRd2]]></description>
</item>

<item rdf:about="http://twitter.com/FierceBiotech/statuses/5365831905">
<title>GTx shares blitzed by FDA&#x27;s toremifene rejection. http://is.gd/4L8LV</title>
<link>http://twitter.com/FierceBiotech/statuses/5365831905</link>
<description><![CDATA[GTx shares blitzed by FDA&apos;s toremifene rejection. http://is.gd/4L8LV]]></description>
</item>

<item rdf:about="http://twitter.com/BiotechNews/statuses/5365800432">
<title>GTx shares blitzed by FDA&#x27;s toremifene rejection: Shares of GTx (GTXI) tumbled 34 percent in premarket trading .. http://bit.ly/2YcRd2</title>
<link>http://twitter.com/BiotechNews/statuses/5365800432</link>
<description><![CDATA[GTx shares blitzed by FDA&apos;s toremifene rejection: Shares of GTx (GTXI) tumbled 34 percent in premarket trading .. http://bit.ly/2YcRd2]]></description>
</item>

<item rdf:about="http://twitter.com/techflypaper/statuses/5365122309">
<title>GTx Receives Complete Response Letter from FDA for Toremifene 80 mg New Drug Application http://bit.ly/14WGE6</title>
<link>http://twitter.com/techflypaper/statuses/5365122309</link>
<description><![CDATA[GTx Receives Complete Response Letter from FDA for Toremifene 80 mg New Drug Application http://bit.ly/14WGE6]]></description>
</item>

<item rdf:about="http://twitter.com/cafepharma/statuses/5364993892">
<title>GTx slides after FDA asks for more toremifene data- Yahoo/AP http://bit.ly/1aX23M</title>
<link>http://twitter.com/cafepharma/statuses/5364993892</link>
<description><![CDATA[GTx slides after FDA asks for more toremifene data- Yahoo/AP http://bit.ly/1aX23M]]></description>
</item>

<item rdf:about="http://twitter.com/biotechnology/statuses/5363874752">
<title>GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required : http://bit.ly/4oCUlx</title>
<link>http://twitter.com/biotechnology/statuses/5363874752</link>
<description><![CDATA[GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required : http://bit.ly/4oCUlx]]></description>
</item>

<item rdf:about="http://twitter.com/pharmaceutical/statuses/5363872002">
<title>GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required : http://bit.ly/4oCUlx</title>
<link>http://twitter.com/pharmaceutical/statuses/5363872002</link>
<description><![CDATA[GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required : http://bit.ly/4oCUlx]]></description>
</item>

<item rdf:about="http://twitter.com/PharmaNews/statuses/5363606737">
<title>GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required http://bit.ly/4oCUlx</title>
<link>http://twitter.com/PharmaNews/statuses/5363606737</link>
<description><![CDATA[GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required http://bit.ly/4oCUlx]]></description>
</item>

<item rdf:about="http://twitter.com/biotechrss/statuses/5363606714">
<title>BioSpace News: GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required:... http://bit.ly/4oCUlx</title>
<link>http://twitter.com/biotechrss/statuses/5363606714</link>
<description><![CDATA[BioSpace News: GTx, Inc. Receives Complete Response Letter from FDA for Toremifene 80 mg NDA; More Studies Required:... http://bit.ly/4oCUlx]]></description>
</item>

</rdf:RDF>